Withdrawal-emergent dyskinesia in a patient on risperidone undergoing dosage reduction.
نویسندگان
چکیده
A 23-year-old, white male with history of paranoid schizophrenia developed a withdrawal-emergent dyskinesia during a dose reduction of risperidone. The implications of this with regard to future risk of tardive dyskinesia (TD) and the potential association of risperidone with TD are discussed.
منابع مشابه
Amisulpride withdrawal dyskinesia: a case report
BACKGROUND The effects of antipsychotic drug withdrawal have been inadequately studied. Case reports have described dyskinesia occurring in patients with several antipsychotics withdrawn, but studies on amisulpride withdrawal dyskinesia are lacking. CASE PRESENTATION A 63-year-old man, who was diagnosed with schizophrenia at age 49, received amisulpride treatment since age 62. The dosage of a...
متن کاملWithdrawal-Emergent Dyskinesia and Supersensitivity Psychosis Due to Olanzapine Use.
Tardive dyskinesia (TD) usually appears after years of antipsychotic drug use and appears to be related to the total lifetime medication dose. In withdrawal-emergent dyskinesia (WE-D), which is considered to be a subtype of TD, dyskinetic symptoms often appear shortly after a rapid reduction in antipsychotic drug dose or sudden discontinuation of the drug. Supersensitivity psychosis, which is f...
متن کاملEvaluating movement disorders in pediatric patients receiving risperidone: a comparison of spontaneous reports and research criteria for TD
BACKGROUND Movement disorders (MD) in children are relatively common and may be associated with medication use. Objective methods (ie rating scales) and specific research criteria may be helpful in identifying MD-related adverse events that would otherwise not be apparent from spontaneous reports. We assessed whether more stringent and rigorous criteria would provide MD rates similar to those d...
متن کاملTardive dyskinesia occurring in a young woman after withdrawal of an atypical antipsychotic drug.
Tardive dyskinesia (TD) is one of the most serious and disturbing side-effects of dopamine receptor antagonists. It affects 20-50% of patients on long-term antipsychotic therapy. The pathophysiology of TD remains poorly understood, and treatment is often challenging. Here, we present a 32-year-old woman presenting with a 9-month history of TD occurring after risperidone withdrawal, and characte...
متن کاملCASE REPORT Two cases of risperidone-induced tardive dyskinesia and a review of the literature
A case in which a 26 year old patient with undifferentiated schizophrenia, showing abnormal oral, lingual and jaw movements suggestive of tardive dyskinesia during a dose reduction of risperidone, is presented. A second case, relating to a 39 year old married woman diagnosed as having a DSM-IV schizophreniform disorder is also presented. These two cases are discussed in relation to the existing...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists
دوره 8 3 شماره
صفحات -
تاریخ انتشار 1996